Showing 7111-7120 of 20410 results for "".
How Does COVID-19 Affect the Heart?
https://reachmd.com/programs/heart-matters/how-does-covid-19-affect-the-heart/11868/COVID-19 not only impacts the lungs, but also the heart. How are these effects different than what we expected?Navigating the Road Toward Healthcare Reform: Single-Payer Pros & Cons
https://reachmd.com/programs/voices-from-american-medicine/navigating-the-road-toward-healthcare-reform-single-payer-pros-cons/11204/Which healthcare reform policy stands a better chance of improving patient care: a single-payer model, a privatized one, or something in between?Detangling Difficult Conversations About Multiple Sclerosis: Clinical Exchanges
https://reachmd.com/programs/cme/detangling-difficult-conversations-about-multiple-sclerosis-clinical-exchanges/10627/This conversation-centered activity with educational pearls takes learners through a clinical exchange between patients with MS and their providers.Suffering in Silence: The Social Stigma of Menopause for Patients
https://reachmd.com/programs/everyday-family-medicine/suffering-silence-social-stigma-menopause-patients/8288/Dr. Jennifer Caudle talks about the importance of talking to patients about menopausal symptoms and stigmas, and ways to address bothTau Therapies and Clinical Translation: Mechanistic Approaches
https://reachmd.com/programs/cme/tau-therapies-and-clinical-translation-mechanistic-approaches/56762/Examine integrated neurodegenerative and neuropsychiatric features of Alzheimer’s disease, including NPS biology and therapeutic strategies.NPS Psychosis: Circuits, Treatment, and New Hope
https://reachmd.com/programs/cme/nps-psychosis-circuits-treatment-and-new-hope/56765/Examine integrated neurodegenerative and neuropsychiatric features of Alzheimer’s disease, including NPS biology and therapeutic strategies.Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
https://reachmd.com/programs/cme/engaging-your-patient-shared-decision-making-in-hf-with-lvef40/29910/Engaging Your Patient: Shared Decision-Making in HF With Preserved Ejection FractionGDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
https://reachmd.com/programs/cme/gdmt-is-working-fine-why-add-more-therapies-the-clinical-rationale-for-layering-therapies-in-patients-with-hfref/54632/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
https://reachmd.com/clinical-practice/cardiology/evolocumab-in-patients-at-high-cardiovascular-risk-without-prior-mi-or-stroke-primary-results-of-the-vesalius-cv-trial/39889/Explore VESALIUS-CV trial results on evolocumab for cardiovascular risk reduction in patients without prior MI or stroke who are at high cardiovascular risk.Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
https://reachmd.com/programs/cme/Sustaining-Visual-Benefits-of-Photobiomodulation-in-Dry-Age-Related-Macular-Degeneration/35948/Learn about multiwavelength PBM for the treatment of dry AMD, including the MOA, administration, eff